dihexa pnb-0408 c-met hgfr activator Buy – CAS 1401708-83-5 Pancreatic Cancer Treatment Targeting the
Pancreatic Cancer Treatment Targeting the HGF c MET Pathway: The MEK Inhibitor Trametinib dihexa dementia Dihexa (PNB 0408) c Met HGFR Activator Negative control of the HGF c MET pathway by TGF : a new look at the regulation of stemness in glioblastoma Cell Death & Disease dihexa chemical properties solubility stability Cabozantinib hydrochloride c Met inhibitor CAS 1817759 42 4 HGF c MET pathway in cancer: from molecular characterization to clinical evidence Oncogene The HGF c Met Axis: A Promising Therapeutic Target in Cancer Frontiers Research Topic
Pay in 4 interest-free payments of $6.73 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7





